Loading
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Oct 2023 for MiNK Therapeutics, Inc., €3,311. Read the official filing
Filing timeline
BuySaleAgenus Inc
Insider track record
Disclosed buys
7
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-74.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Agenus Inc: trading record in brief
Agenus Inc discloses dealings in MiNK Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 19 October 2021 to 12 October 2023, the count stands at 9 filings.
Every open-market trade on record is a purchase: 7 purchases worth €14.9M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2023 to date brings 6 purchases and no sales.
A typical purchase (the median) is worth €41k. On 2 out of 7 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 16 October 2023, the filings show an open-market purchase worth €3,311 in MiNK Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Agenus Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
3,173 shares@ US$1.09940.0% of flowCommon StockSEC:0000950170-23-053601:0
Canonical exit: 10 Jan 2024 (T+90)
15,001 shares@ US$1.09190.1% of flowCommon StockSEC:0000950170-23-052408:0
Canonical exit: 2 Jan 2024 (T+90)
29,678 shares@ US$1.51680.1% of flowCommon StockSEC:0000950170-23-045816:0
Canonical exit: 27 Nov 2023 (T+90)
170,244 shares@ US$1.54430.8% of flowCommon StockSEC:0000899243-23-018546:0
Canonical exit: 22 Nov 2023 (T+90)
5,006,397 shares0Common StockSEC:0000950170-23-024556:0
22,065 shares@ US$1.5090.1% of flowCommon StockSEC:0000950170-23-021854:0
Canonical exit: 8 Aug 2023 (T+90)
128,689 shares@ US$1.07890.4% of flowCommon StockSEC:0000950170-23-018401:0
Canonical exit: 1 Aug 2023 (T+90)
4,988,273 shares0Common StockSEC:0000899243-23-012119:0
1,400,000 shares@ US$12.0096.9% of flowCommon StockSEC:0000899243-21-040873:0
Canonical exit: 17 Jan 2022 (T+90)
9 of 9 declarations
